Medical digital twins, which represent medical assets, play a crucial role in connecting the physical world to the metaverse, enabling patients to access virtual medical services and experience immersive interactions with the real world. One serious disease that can be diagnosed and treated using this technology is cancer. However, the digitalization of such diseases for use in the metaverse is a highly complex process. To address this, this study aims to use machine learning (ML) techniques to create real-time and reliable digital twins of cancer for diagnostic and therapeutic purposes. The study focuses on four classical ML techniques that are simple and fast for medical specialists without extensive Artificial Intelligence (AI) knowledge, and meet the requirements of the Internet of Medical Things (IoMT) in terms of latency and cost. The case study focuses on breast cancer (BC), the second most prevalent form of cancer worldwide. The study also presents a comprehensive conceptual framework to illustrate the process of creating digital twins of cancer, and demonstrates the feasibility and reliability of these digital twins in monitoring, diagnosing, and predicting medical parameters.

Advanced mathematical and deep learning (DL) algorithms have recently played a crucial role in diagnosing medical parameters and diseases. One of these areas that need to be more focused on is dentistry. This is why creating digital twins of dental issues in the metaverse is a practical and effective technique to benefit from the immersive characteristics of this technology and adapt the real world of dentistry to the virtual world. These technologies can create virtual facilities and environments for patients, physicians, and researchers to access a variety of medical services. Experiencing an immersive interaction between doctors and patients can be another considerable advantage of these technologies, which can dramatically improve the efficiency of the healthcare system. In addition, offering these amenities through a blockchain system enhances reliability, safety, openness, and the ability to trace data exchange. It also brings about cost savings through improved efficiencies. In this paper, a digital twin of cervical vertebral maturation (CVM), which is a critical factor in a wide range of dental surgery, within a blockchain-based metaverse platform is designed and implemented. A DL method has been used to create an automated diagnosis process for the upcoming CVM images in the proposed platform. This method includes MobileNetV2, a mobile architecture that improves the performance of mobile models in multiple tasks and benchmarks. The proposed technique of digital twinning is simple, fast, and suitable for physicians and medical specialists, as well as for adapting to the Internet of Medical Things (IoMT) due to its low latency and computing costs. One of the important contributions of the current study is to use of DL-based computer vision as a real-time measurement method so that the proposed digital twin does not require additional sensors. Furthermore, a comprehensive conceptual framework for creating digital twins of CVM based on MobileNetV2 within a blockchain ecosystem has been designed and implemented, showing the applicability and suitability of the introduced approach. The high performance of the proposed model on a collected small dataset demonstrates that low-cost deep learning can be used for diagnosis, anomaly detection, better design, and many more applications of the upcoming digital representations. In addition, this study shows how digital twins can be performed and developed for dental issues with the lowest hardware infrastructures, reducing the costs of diagnosis and treatment for patients.

In the era of digitalization and artificial intelligence (AI), the utilization of Metaverse technology has become increasingly crucial. As the world becomes more digitized, there is a pressing need to effectively transfer real-world assets into the digital realm and establish meaningful relationships between them. However, existing approaches have shown significant limitations in achieving this goal comprehensively. To address this, this research introduces an innovative methodology called the Meta-Metaverse, which aims to enhance the immersive experience and create realistic digital twins across various domains such as biology, genetics, economy, medicine, environment, gaming, digital twins, Internet of Things, artificial intelligence, machine learning, psychology, supply chain, social networking, smart manufacturing, and politics. The multi-layered structure of Metaverse platforms and digital twins allows for greater flexibility and scalability, offering valuable insights into the potential impact of advancing science, technology, and the internet. This article presents a detailed description of the proposed methodology and its applications, highlighting its potential to transform scientific research and inspire groundbreaking ideas in science, medicine, and technology.

The global spread of COVID-19 highlights the urgency of quickly finding drugs and vaccines and suggests that similar challenges will arise in the future. This underscores the need for ongoing efforts to overcome the obstacles involved in the development of potential treatments. Although some progress has been made in the use of Artificial Intelligence (AI) in drug discovery, virologists, pharmaceutical companies, and investors seek more long-term solutions and greater investment in emerging technologies. One potential solution to aid in the drug-development process is to combine the capabilities of the Internet of Medical Things (IoMT), edge computing (EC), and deep learning (DL). Some practical frameworks and techniques utilizing EC, IoMT, and DL have been proposed for the monitoring and tracking of infected individuals or high-risk areas. However, these technologies have not been widely utilized in drug clinical trials. Given the time-consuming nature of traditional drug- and vaccine-development methods, there is a need for a new AI-based platform that can revolutionize the industry. One approach involves utilizing smartphones equipped with medical sensors to collect and transmit real-time physiological and healthcare information on clinical-trial participants to the nearest edge nodes (EN). This allows the verification of a vast amount of medical data for a large number of individuals in a short time frame, without the restrictions of latency, bandwidth, or security constraints. The collected information can be monitored by physicians and researchers to assess a vaccine’s performance.

This research introduces a novel approach by incorporating various types of gelatins, including bovine, porcine, and fish skin, into polycaprolactone and poly (lactic-co-glycolic acid) using a solvent casting method. The films are evaluated for morphology, mechanical properties, thermal stability, biodegradability, hemocompatibility, cell adhesion, proliferation, and cytotoxicity. The results show that the incorporation of gelatins into the films alters their mechanical properties, with a decrease in tensile strength but an increase in elongation at break. This indicates that the films become more flexible with the addition of gelatin. Gelatin incorporation has a limited effect on the thermal stability of the films. The composites with the gelatin show higher biodegradability with the highest weight loss in the case of fish gelatin. The films exhibit high hemocompatibility with minimal hemolysis observed. The gelatin has a dynamic effect on cell behavior and promotes long-term cell proliferation. In addition, all composite films reveal exceptionally low levels of cytotoxicity. The combination of the evaluated parameters shows the appropriate level of biocompatibility for gelatin-based samples. These findings provide valuable insights for future studies involving gelatin incorporation in tissue engineering applications.